Yüklüyor......

Targeting protein-protein interactions in hematologic malignancies: still a challenge or a great opportunity for future therapies?

Over the past several years, there has been an increasing research effort focused on inhibition of protein-protein interactions (PPIs) to develop novel therapeutic approaches for cancer, including hematologic malignancies. These efforts have led to development of small molecule inhibitors of PPIs, s...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Immunol Rev
Asıl Yazarlar: Cierpicki, Tomasz, Grembecka, Jolanta
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2015
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4457300/
https://ncbi.nlm.nih.gov/pubmed/25510283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/imr.12244
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!